july10

FAQ's

Answer : According to Precedence Research, the cancer drugs market was valued at US$ 136.2 billion in 2020 and is expected to reach valuation US$ 272 billion by 2030.

Answer : The cancer drugs market is growing at a noteworthy CAGR of 7.2% from 2021 to 2030.

Answer : The major players operating in the cancer drugs market are Amgen, Bayer Healthcare AG, CELGENE CORPORATION, GlaxoSmithKline, ARIAD Pharmaceuticals, Inc., Eli Lilly and Company, Novartis, Hoffmann-La Roche Ltd., AstraZeneca, BoehringerIngelheim GmbH, Pfizer, Teva Pharmaceuticals Industries.

Answer : The rising prevalence of various types of cancer such as lungs cancer, colorectal cancer, bowel cancer, breast cancer, and various other types of cancer is the most prominent factor that boosts the growth of the global cancer drugs market.

Answer : The North America region will lead the global cancer drugs market